anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Source Note

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 110,355
Current window 58,411-58,440
Pages 3,679
Rows per page 30
Component: Source Noteclear collectionreset all
18 30 60

Component

58,411-58,440 of 110,355

filter-aware
39
The slide uses a structured 4-column layout to summarize the disease profile.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
40
The slide depicts a step-by-step biological pathway (1-6) showing how autoantibodies lead to blister formation. It also highlights the therapeutic target Efgartigimod.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
42
The funnel structure implies a progression toward higher selectivity and better outcomes.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
43
The slide presents three distinct clinical datasets (IVIg, Protein A Immunoadsorption, and PLEX) to support the thesis that IgG-targeted therapies lead to fast remissions.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
56
The slide uses a timeline-like structure to show dose escalation cohorts for IV and SC administration.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
57
The slide presents clinical trial safety data for ARGX-117, highlighting that most adverse events are low grade and unrelated to the drug.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
62
The slide highlights the clinical burden and market opportunity for new therapies.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
66
The slide uses a before-after comparison to demonstrate the efficacy of ARGX-117 in preserving neurofilaments.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
06
The slide uses a process-like flow to connect disease categories to specific autoantibody findings and clinical trial/regulatory status.argenx SE | Results Presentation Deck | 16 slides · argenx
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
03
Includes a footnote regarding board diversity.Aston Martin | Results Presentation Deck | 25 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Situation & Context1 hit
08
The slide uses a waterfall chart to explain the variance in EBITDA, followed by a detailed PBT reconciliation table.Aston Martin | Results Presentation Deck | 25 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Evidence & ProofLoop · Mece Breakdown1 hit
10
The waterfall chart illustrates the bridge between opening and closing cash balances.Aston Martin | Results Presentation Deck | 25 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Solution & ApproachLoop · Jobs To Be Done1 hit
19
Includes footnotes regarding APMs, share consolidation, and cash availability.Aston Martin | Results Presentation Deck | 25 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
20
APM stands for Alternative Performance Measures.Aston Martin | Results Presentation Deck | 25 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
22
Includes footnotes regarding APMs, Specials, and restatements.Aston Martin | Results Presentation Deck | 25 slides · Aston Martin Lagonda
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
01
Slide 1
AstraZeneca | Results Presentation Deck | 42 slidesAstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
05
Includes footnotes explaining abbreviations and specific financial exclusions.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Attention1 hit
06
The slide uses a table to categorize pipeline progress into regulatory approvals, submissions, and phase III data readouts.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Pattern Hunter1 hit
07
The slide uses a combination of a bar chart for historical growth trends and a waterfall-style bar chart for new medicine revenue contribution.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Pattern Hunter1 hit
08
The slide presents two distinct tables side-by-side, comparing performance by therapeutic area and by geography.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · NeedLoop · Pattern Hunter1 hit
11
The slide uses a consistent color-coding scheme for regions (US, Europe, ERoW, EM) across both products.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
14
The slide uses a background image of a human torso with cellular/molecular overlays, typical of pharmaceutical corporate presentations.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · SatisfactionLoop · Pattern Hunter1 hit
15
The slide uses stacked bar charts to show revenue composition over time from Q1 2018 to Q2 2021.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
18
The chart shows a stacked bar chart of revenue over time, split by China and EM excluding China.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
19
Includes a table of revenue by product and a list of reporting milestones.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Satisfaction1 hit
22
Includes a footnote regarding exchange rates and gross margin calculation methodology.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
23
The slide uses a stacked bar chart for profit mix and a waterfall chart for net debt bridge.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
27
Slide 27 of a presentation, likely from AstraZeneca.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · Action1 hit
28
The slide uses Kaplan-Meier survival curves to demonstrate efficacy in two major Phase III trials.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
29
The slide uses a three-column layout to summarize clinical efficacy, market need, and future pipeline milestones.AstraZeneca | Results Presentation Deck | 42 slides · AstraZeneca
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit